PFKP and pancreatic neoplasm: In agreement with the in vitro results, EGCG reduced the levels of PFKP and PKM2 (p < 0.01 for both) in pancreatic tumor xenograft homogenates, obtained from mice treated with EGCG (Figure 2D, Figure S6).